Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2012
07/19/2012WO2012069658A3 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
07/19/2012WO2012064301A3 Physically improved tablet formulations
07/19/2012WO2012045089A3 Methods for the treatment of allergic diseases
07/19/2012WO2011130434A9 Antibodies that bind human cd27 and uses thereof
07/19/2012US20120184616 Methods for treating inflammation
07/19/2012US20120184604 Composition for the prevention or treatment of bone diseases comprising colforsin daropate
07/19/2012US20120184583 Modulators of atp-binding cassette transporters
07/19/2012US20120184579 Quinolines and Their Therapeutic Use
07/19/2012US20120184569 A3 adenosine receptor agonists and antagonists
07/19/2012US20120184567 Inhibitors of bruton's tyrosine kinase
07/19/2012US20120184540 1,4 oxazines as bace1 and/or bace2 inhibitors
07/19/2012US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
07/19/2012US20120184526 Compounds and compositions as syk kinase inhibitors
07/19/2012US20120184524 Pyrazolopyridine kinase inhibitors
07/19/2012US20120184523 C-Met Modulators and Method of Use
07/19/2012US20120184519 Compositions and Methods for Preventing or Treating Influenza Virus Infection
07/19/2012US20120184516 sGC Stimulators
07/19/2012US20120184511 Novel Pharmaceutical Composition Comprising a Macrolide Immunosuppressant Drug
07/19/2012US20120184499 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
07/19/2012US20120184496 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
07/19/2012US20120184493 Dermal formulations of dp2 receptor antagonists
07/19/2012US20120183632 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
07/19/2012US20120183599 Pharmaceutical Composition
07/19/2012US20120183597 Method of inducing neutralizing antibodies to human immunodeficiency virus
07/19/2012US20120183595 Transdermal Pharmaceutical Delivery Composition
07/19/2012US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
07/19/2012US20120183579 Compounds for inflammation and immune-related uses
07/19/2012US20120183578 Polyethylene glycol-based dendrons
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183576 Modified gram-negative bacteria for use as vaccines
07/19/2012US20120183575 Exosome based treatment of cancer
07/19/2012US20120183569 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
07/19/2012US20120183568 Bioassay for the early detection of autoimmune diseases
07/19/2012US20120183565 Fully human antibodies to btla
07/19/2012US20120183563 Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use
07/19/2012US20120183561 Alpha-4-beta-7 heterodimer specific antagonist antibody
07/19/2012US20120183557 Hiv tat-cd4 hybrid molecules and methods of use thereof
07/19/2012US20120183554 Biomarker
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183543 Diagnostic biomarkers for fibrotic disorders
07/19/2012US20120183533 Mimotopes of hiv env
07/19/2012US20120183530 Stabilized immune modulatory rna (simra) compounds
07/19/2012US20120183523 Methods and Compounds for Promoting Vessel Regression
07/19/2012US20120183515 Oral nutritional supplement comprising probiotics
07/19/2012US20120183514 Infant cereal comprising non-replicating probiotic microorganisms
07/19/2012US20120183513 Lactobacillus Supplement for Alleviating Type I Diabetes
07/19/2012US20120183506 Prevention and treatment of allergic diarrhoea
07/19/2012US20120183497 Method of Determining Response to Treatment with Immunomodulatory Composition
07/19/2012CA2824786A1 Substituted benzoazepines as toll-like receptor modulators
07/19/2012CA2824313A1 Tlr3 binding agents
07/19/2012CA2824151A1 Antigen surrogates in autoimmune disease
07/19/2012CA2824060A1 Anti-tlr4 antibodies and methods of use thereof
07/19/2012CA2823782A1 Enhancement of allogeneic hematopoietic stem cell transplantation
07/18/2012EP2476752A1 Process for production of natural killer cells
07/18/2012EP2475667A1 Inhibitors of jak
07/18/2012EP2475648A1 Ortho substituted pyrimidine compounds as jak inhibitors
07/18/2012EP2475393A2 Formulation for room temperature stabilization of a live attenuated bacterial vaccine
07/18/2012EP2475381A2 Methods for hematopoietic precursor mobilization
07/18/2012EP2475379A2 Cd117+cells and uses thereof
07/18/2012EP2399993A9 Hypo-immunogenic streptavidin and use thereof
07/18/2012EP1959990B1 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
07/18/2012EP1470148B1 Double-stranded oligonucleotides
07/18/2012EP1432735B1 Antagonistic anti-htnfsf13b human antibodies
07/18/2012CN1935260B Human antibodies that bind human tnfalpha
07/18/2012CN1839202B Process for producing cytotoxic lymphocytes
07/18/2012CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta
07/18/2012CN102597223A Process for production of natural killer cells
07/18/2012CN102597216A Novel lactobacillus plantarum and composition comprising the same
07/18/2012CN102597003A Compositions and methods for treating inflammatory disorders
07/18/2012CN102596962A Inhibitors of JAK
07/18/2012CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
07/18/2012CN102596244A 丙型肝炎病毒疫苗组合物 HCV vaccine composition
07/18/2012CN102596229A Glucagon-like peptide-1 receptor (GLP-1R) agonists for treating autoimmune disorders
07/18/2012CN102596222A Dermaseptin B2 used as an inhibitor of the growth of a tumor
07/18/2012CN102596216A Therapeutic preparation for rhinitis
07/18/2012CN102596196A Methods for inducing programmed cell death
07/18/2012CN102586377A Concentrate containing carotenoid monomer and preparation method as well as application thereof
07/18/2012CN102586261A Portunus trituberculatus PtCrustin-2 gene, and coded protein and application thereof
07/18/2012CN102586260A PtCrustin-1 gene of Portunus trituberculatus, encoding protein of PtCrustin-1 gene and application of PtCrustin-1 gene
07/18/2012CN102586182A Preparation and application of human-stem-cell-secreted bioactive factor and lysis solution
07/18/2012CN102586161A Mycobacterium smegmatis IL-17A and preparation method thereof
07/18/2012CN102586066A Health-care wine and preparation method thereof
07/18/2012CN102586064A Nutrition wine for nourishing yin and invigorating kidney
07/18/2012CN102586006A Method for deeply developing and comprehensively utilizing medicinal and edible plant sea buckthorn
07/18/2012CN102585202A Dendritic polyglycerol sulfates and sulfonates and their use for inflammatory diseases
07/18/2012CN102585032A Water-soluble polysaccharide extracted from black fungus and preparation method thereof
07/18/2012CN102585029A Preparation method and application of physiologically active notoginseng polysaccharide
07/18/2012CN102585022A Method for extracting polysaccharides from decoction dregs left after extraction of total alkaloids of sophora alopecuroides
07/18/2012CN102585016A Immune fusion protein capable of inhibiting T and B lymphocyte functions and preparation method and application thereof
07/18/2012CN102585002A High affinity antibodies to human il-6 receptor
07/18/2012CN102584998A Canine thymic stromal lymphopoietin protein and uses thereof
07/18/2012CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
07/18/2012CN102584966A Recombinant peanut allergen and mutant and preparation method and application of recombinant peanut allergen and mutant
07/18/2012CN102584924A Application of carbon-21 steride compound
07/18/2012CN102584830A Dihydroindene amide compounds, and medicinal composition and application thereof
07/18/2012CN102584826A (6S)-5-methyl tetrahydrofolate crystal form and preparation method thereof
07/18/2012CN102580082A Inactived vaccine for poultry and preparation method thereof
07/18/2012CN102580070A Compositions for Immunizing Against Mycobacterium
07/18/2012CN102580069A Eye-drop vaccine containing copolymer 1 for therapeutic immunization
07/18/2012CN102580064A Medicinal application of superoxide dismutase (SOD) to treatment of rhinitis
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 1172